Epidemiology And Laboratory Capacity (ELC) in Rhode Island
USAspending.gov records $293,973,010.78 in Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) obligations (CFDA 93.323) with place of performance in Rhode Island, across 1 awards. A single award carries the entire cell, so the implied mean equals the total. That pattern is typical of a statewide cooperative agreement or block pass-through, not a roster of household invoices. This page joins the CDC/HHS catalog line to the RI geography tag. It is not a case-count chart or a ranking of laboratories by test volume. Obligations are commitments, not outlays.
Key figures
- CFDA 93.323 shows $293,973,010.78 in Rhode Island obligations on 1 awards.
- Mean obligation is about $293.97 million per award (ratio only).
- The join is Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) × Rhode Island place of performance, not an outbreak timeline or NIH research awards.
- Figures are USAspending obligations, not outlays.
- CDC/HHS catalog 93.323 is not Rhode Island’s full federal total.
One ELC award carries Rhode Island’s 93.323 cell
CFDA 93.323 is titled Epidemiology And Laboratory Capacity For Infectious Diseases (Elc). Filtered to Rhode Island place of performance, obligations sum to $293,973,010.78 on 1 awards. The national CFDA 93.323 hub includes every state. Rhode Island federal spending includes every program. This tie is the overlap — the pair, not a causal story. ELC funding often posts as a large cooperative agreement with a state health department. One or a few primes can carry a statewide laboratory-capacity book.
A single award carries the entire cell, so the implied mean equals the total. That pattern is typical of a statewide cooperative agreement or block pass-through, not a roster of household invoices. Readers sometimes treat a large CFDA–state total as if it were a budget line the state legislature passed. $293,973,010.78 is not that. It is the USAspending obligation sum on awards tagged 93.323 and RI. Correlation is not causation. Campaign-finance tables are a different dataset; donations do not fund these awards.
ELC is not NIH infectious-disease research
NIH allergy and infectious-diseases research (93.855) and other CDC operations lines are different catalogs. Folding them here would misstate the ELC cell. Packet facts are Rhode Island, CFDA 93.323, $293,973,010.78, and 1 awards. Formula shares, recipient lists, and outcome scores are not in the facts. The catalog title names Epidemiology And Laboratory Capacity For Infectious Diseases (Elc), not an outbreak timeline or NIH research awards.
The only numeric facts on this packet are $293,973,010.78, 1 awards, CFDA 93.323, program title Epidemiology And Laboratory Capacity For Infectious Diseases (Elc), and geography RI/Rhode Island. Any other dollar, year, recipient, or percentage would be invented. Trivial arithmetic is allowed: 1 awards into $293,973,010.78 is about $293.97 million per award. That quotient is a mean of records, not a typical household, student, patient, or ELC unit.
Rhode Island as a statewide laboratory tag
Rhode Island is a small geography, so a statewide place-of-performance tag is a common filing pattern. Providence is not a separate column. Awards coded to Massachusetts or Connecticut stay on other ties even when labs or offices sit near the border. Place of performance RI is a two-letter code in the award file. It does not prove where every subcontract ran, and it does not convert $293,973,010.78 into a county map. Awards with a different state code are outside this cell even if people, patients, or riders cross the border.
Rhode Island federal spending is the all-program parent. CFDA 93.323 is the national program page without the Rhode Island filter. Rhode Island programs lists other catalogs beside Epidemiology And Laboratory Capacity For Infectious Diseases (Elc). $293,973,010.78 is not Rhode Island’s complete federal footprint.
A single instrument and a matching mean
$293,973,010.78 ÷ 1 is about $293.97 million per award. That average is a ratio of two packet facts, not a median and not a posted unit price. With n = 1, a few large instruments can dominate, or many small actions can stack. Treat one as a record count in an aggregate, not as one finished projects. USAspending obligations can be positive new awards or net of downward modifications; $293,973,010.78 is the net total supplied in the facts.
Without a transaction register on this page, you cannot see how many of the 1 rows are continuations, renewals, or corrections. Unique recipients are unpublished. Pathogen lists and test volumes are unpublished. One prime to a state health department is a common ELC filing pattern, not a count of outbreaks.
What the ELC × Rhode Island pair cannot prove
An obligation is a legal commitment. An outlay is a payment. $293,973,010.78 is the former. This packet has no outlay total, no fiscal-year split, and no de-obligation history. Citing the figure as cash already cleared in Rhode Island over-reads the field. Keep the obligation word when you quote Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Rhode Island. FEC filings do not pay USAspending cells. The join cannot say that Rhode Island specialized in ELC because of federal demand, or the reverse.
Hubs around CFDA 93.323 in Rhode Island
The overlay target is Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Rhode Island. Open that path for the same $293,973,010.78 / 1-award cell in the site’s data chrome. CFDA 93.323 drops the Rhode Island filter. Rhode Island federal spending drops the CFDA filter. Rhode Island programs lists sibling catalogs. All spending ties is the directory of other pairs. None of those links convert the cell into an outbreak timeline or NIH research awards, into outlays this packet omits, or into a causal claim. Cite both sides: Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and Rhode Island, $293,973,010.78, 1 awards, USAspending.gov, obligations only.
Questions
- How much ELC funding is obligated in Rhode Island?
- USAspending.gov records $293,973,010.78 in Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) obligations (CFDA 93.323) with Rhode Island place of performance across 1 awards. That is an obligation aggregate for the program–state pair, not an outlay and not Rhode Island’s full federal book. Original filings remain on USAspending.gov.
- Why is there only 1 award for this total?
- The extract lists 1 award actions totaling $293,973,010.78. A single award carries the entire cell, so the implied mean equals the total. That pattern is typical of a statewide cooperative agreement or block pass-through, not a roster of household invoices. Average obligation per award is about $293.97 million, a ratio of two packet facts, not a typical invoice. Unique recipients are not published on this packet.
- Is this Rhode Island’s full public-health spending?
- No. $293,973,010.78 is only the Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) cell tagged to Rhode Island. Other CFDA programs with Rhode Island place of performance sit on Rhode Island federal spending. Nationwide CFDA 93.323 is not limited to Rhode Island. Mixing sibling catalogs into this total would overstate the join.
- Which pages sit next to this ELC tie?
- Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Rhode Island is the live table for this pair. CFDA 93.323 is the national program hub. Rhode Island federal spending is the statewide parent. Rhode Island programs indexes other catalogs. All spending ties lists other pairs. Prefer those tables after later USAspending ingests; this page quotes only 93.323 × RI at $293,973,010.78.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.